FDA is expected to put out a HARD STOP on all monovalent Moderna and Pfzier mRNA products either this Friday (4.14.2023) or Monday (4.17.2023). Though monovalent products are still active for ordering, all Moderna or Pfizer Monovalent orders submitting this week will be rejected. Sites will be contacted to see if they want to switch to a bivalent product to complete these orders.

Bivalent products will be approved for primary and booster doses. ACIP will also approve a new bivalent schedule for 65yrs+ and immunocompromised individuals. Please look out for this information soon.